InvestorsHub Logo
Followers 27
Posts 3761
Boards Moderated 0
Alias Born 05/31/2011

Re: Mr Sensitivity post# 9970

Friday, 11/08/2013 9:44:49 PM

Friday, November 08, 2013 9:44:49 PM

Post# of 97081
Thx for sharing. The article wasn't posted on this mb, but is on the company website. My favorite parts of the article:

With the injunction lifted, Shasta and Decision Diagnostics are set to "fully implement its rollout strategy for GenStrip," the companies said. With a new line of credit and its legal win in hand, Decision Diagnostics estimates that it could begin bagging annual revenues of more than $250 million.

The could be a major blow to LifeScan's business model, which relies for revenue more on sales of the strips than on the OneTouch meters themselves....

Decision Diagnostics says its strips cost up to 50% less than rival strips, and its management says it's confident that it can capture market share.